IL127487A - Use of thiazolidinone derivatives for the preparation of drugs for the treatment of neurodegenerative diseases - Google Patents
Use of thiazolidinone derivatives for the preparation of drugs for the treatment of neurodegenerative diseasesInfo
- Publication number
- IL127487A IL127487A IL12748797A IL12748797A IL127487A IL 127487 A IL127487 A IL 127487A IL 12748797 A IL12748797 A IL 12748797A IL 12748797 A IL12748797 A IL 12748797A IL 127487 A IL127487 A IL 127487A
- Authority
- IL
- Israel
- Prior art keywords
- thiazolidinone
- eae
- neurodegenerative disorders
- cells
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2157196P | 1996-07-11 | 1996-07-11 | |
| PCT/US1997/011586 WO1998002160A1 (en) | 1996-07-11 | 1997-07-01 | Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL127487A0 IL127487A0 (en) | 1999-10-28 |
| IL127487A true IL127487A (en) | 2002-04-21 |
Family
ID=21804973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12748797A IL127487A (en) | 1996-07-11 | 1997-07-01 | Use of thiazolidinone derivatives for the preparation of drugs for the treatment of neurodegenerative diseases |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5912259A (ja) |
| EP (1) | EP0914122B1 (ja) |
| JP (1) | JP2001508028A (ja) |
| KR (1) | KR20000023683A (ja) |
| CN (1) | CN1145481C (ja) |
| AT (1) | ATE250416T1 (ja) |
| AU (1) | AU726664B2 (ja) |
| BR (1) | BR9710467A (ja) |
| CA (1) | CA2255073A1 (ja) |
| CO (1) | CO4940509A1 (ja) |
| DE (1) | DE69725147T2 (ja) |
| DK (1) | DK0914122T3 (ja) |
| ES (1) | ES2205247T3 (ja) |
| HK (1) | HK1020533A1 (ja) |
| HR (1) | HRP970362A2 (ja) |
| IL (1) | IL127487A (ja) |
| NO (1) | NO990076D0 (ja) |
| NZ (1) | NZ332763A (ja) |
| PL (1) | PL331049A1 (ja) |
| PT (1) | PT914122E (ja) |
| TR (1) | TR199900040T2 (ja) |
| WO (1) | WO1998002160A1 (ja) |
| ZA (1) | ZA976142B (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003247514A1 (en) * | 2002-06-11 | 2003-12-22 | Roy Ogle | Meningeal-derived stem cells |
| WO2009137109A1 (en) * | 2008-05-08 | 2009-11-12 | Rutgers, The State University | Endorphin therapy compositions and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL79648A (en) * | 1985-08-09 | 1991-12-12 | Lilly Co Eli | Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation |
| CA2013599C (en) * | 1989-04-07 | 1999-11-16 | Jill A. Panetta | Aryl-substituted rhodanine derivatives |
| US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| CZ181493A3 (en) * | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
| HUP9702293A3 (en) * | 1995-01-23 | 2000-08-28 | Lilly Co Eli | 4-thiazolidinone, rhodanine and 1,3-oxathiolan-5-one derivatives for the preparation of pharmaceutical compositions suitable for the treatment of multiple sclerosis |
| US6136839A (en) * | 1995-06-12 | 2000-10-24 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
-
1997
- 1997-07-01 DK DK97933264T patent/DK0914122T3/da active
- 1997-07-01 TR TR1999/00040T patent/TR199900040T2/xx unknown
- 1997-07-01 NZ NZ332763A patent/NZ332763A/xx unknown
- 1997-07-01 US US09/171,891 patent/US5912259A/en not_active Expired - Fee Related
- 1997-07-01 AU AU36491/97A patent/AU726664B2/en not_active Ceased
- 1997-07-01 BR BR9710467A patent/BR9710467A/pt not_active Application Discontinuation
- 1997-07-01 PT PT97933264T patent/PT914122E/pt unknown
- 1997-07-01 AT AT97933264T patent/ATE250416T1/de not_active IP Right Cessation
- 1997-07-01 JP JP50606698A patent/JP2001508028A/ja not_active Ceased
- 1997-07-01 WO PCT/US1997/011586 patent/WO1998002160A1/en active IP Right Grant
- 1997-07-01 IL IL12748797A patent/IL127487A/en not_active IP Right Cessation
- 1997-07-01 DE DE69725147T patent/DE69725147T2/de not_active Expired - Fee Related
- 1997-07-01 CA CA002255073A patent/CA2255073A1/en not_active Abandoned
- 1997-07-01 CN CNB971960429A patent/CN1145481C/zh not_active Expired - Fee Related
- 1997-07-01 EP EP97933264A patent/EP0914122B1/en not_active Expired - Lifetime
- 1997-07-01 ES ES97933264T patent/ES2205247T3/es not_active Expired - Lifetime
- 1997-07-01 PL PL97331049A patent/PL331049A1/xx unknown
- 1997-07-03 HR HR60/021,571A patent/HRP970362A2/xx not_active Application Discontinuation
- 1997-07-10 ZA ZA9706142A patent/ZA976142B/xx unknown
- 1997-07-10 CO CO97038493A patent/CO4940509A1/es unknown
-
1999
- 1999-01-08 NO NO990076A patent/NO990076D0/no not_active Application Discontinuation
- 1999-01-09 KR KR1019997000140A patent/KR20000023683A/ko active IP Right Grant
- 1999-11-30 HK HK99105554A patent/HK1020533A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5912259A (en) | 1999-06-15 |
| BR9710467A (pt) | 1999-08-17 |
| PL331049A1 (en) | 1999-06-21 |
| DK0914122T3 (da) | 2003-12-22 |
| NZ332763A (en) | 2000-07-28 |
| ZA976142B (en) | 1998-02-02 |
| ATE250416T1 (de) | 2003-10-15 |
| NO990076L (no) | 1999-01-08 |
| KR20000023683A (ko) | 2000-04-25 |
| WO1998002160A1 (en) | 1998-01-22 |
| HK1020533A1 (en) | 2000-05-12 |
| CO4940509A1 (es) | 2000-07-24 |
| EP0914122B1 (en) | 2003-09-24 |
| IL127487A0 (en) | 1999-10-28 |
| EP0914122A1 (en) | 1999-05-12 |
| DE69725147D1 (de) | 2003-10-30 |
| JP2001508028A (ja) | 2001-06-19 |
| NO990076D0 (no) | 1999-01-08 |
| CN1223582A (zh) | 1999-07-21 |
| AU3649197A (en) | 1998-02-09 |
| AU726664B2 (en) | 2000-11-16 |
| DE69725147T2 (de) | 2004-07-22 |
| TR199900040T2 (xx) | 1999-04-21 |
| CN1145481C (zh) | 2004-04-14 |
| PT914122E (pt) | 2003-12-31 |
| CA2255073A1 (en) | 1998-01-22 |
| HRP970362A2 (en) | 1998-04-30 |
| ES2205247T3 (es) | 2004-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102014883B1 (ko) | 근위축성 측삭 경화증 치료용 신규 조성물 | |
| KR102014875B1 (ko) | 파킨슨병을 치료하기 위한 신규의 치료적 접근법 | |
| JP5249388B2 (ja) | 糖尿病の治療及び予防のためのフタリド誘導体の使用 | |
| JP2018514589A5 (ja) | ||
| EP3185859B1 (en) | New therapeutic approaches for treating parkinson's disease | |
| KR20070116632A (ko) | 프로스타글란딘 Ｆ２ａ 유도체를 유효 성분으로서 함유하는망막신경세포 보호제 | |
| NL8802634A (nl) | Therapeutische preparaten. | |
| JP2008526953A (ja) | 炎症性疾患のプラジカンテルでの治療 | |
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| CZ301129B6 (cs) | Farmaceutický prípravek obsahující diacerein pro lécení psoriázy a s ní sdružených onemocnení | |
| JPH0667842B2 (ja) | 基本的うつ病を軽減するためのうつ病治療剤 | |
| JPH0761923A (ja) | アルツハイマー病治療剤 | |
| TWI777059B (zh) | 肌肉減少症之預防劑及治療劑 | |
| EA001325B1 (ru) | Способы лечения и профилактики интерстициального цистита | |
| TW201609640A (zh) | 吲哚基及吲哚啉基異羥肟酸於治療神經退化病症或認知缺乏之用途 | |
| AU726664B2 (en) | Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone | |
| KR101887561B1 (ko) | 간염 바이러스에 의해 유발된 간 섬유화의 개선을 위한 약학 조성물 | |
| RU2307651C2 (ru) | Каппа-опиатные агонисты для лечения заболеваний мочевого пузыря | |
| TW202116297A (zh) | 組合療法之方法、組成物與套組 | |
| WO2023202439A1 (zh) | 二萜化合物衍生物或其盐在制备防治特应性皮炎的药物中的应用 | |
| DK166947B1 (da) | Forbedrede piroxicamholdige praeparater med antiinflammatorisk virkning | |
| JP5575927B2 (ja) | ペントキシフィリンの便秘の予防または治療における応用 | |
| WO2022102819A1 (ko) | 전신경화증 예방 또는 치료용 약학적 조성물 | |
| CN112843065B (zh) | 一种用于认知障碍的药物及其制备方法 | |
| NL2036681A (en) | Application of Naringin Combined with Rapamycin in the Preparation of Medications for Treating Hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |